These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28091594)

  • 101. Functional splicing assay of DSPP mutations in hereditary dentin defects.
    Lee KE; Lee SK; Jung SE; Lee Zh; Kim JW
    Oral Dis; 2011 Oct; 17(7):690-5. PubMed ID: 21736673
    [TBL] [Abstract][Full Text] [Related]  

  • 102. SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma.
    Liang R; Xiao G; Wang M; Li X; Li Y; Hui Z; Sun X; Qin S; Zhang B; Du N; Liu D; Ren H
    Biomed Pharmacother; 2018 Nov; 107():1434-1446. PubMed ID: 30257360
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Prognostic and therapeutic implications of aromatase expression in lung adenocarcinomas with EGFR mutations.
    Kohno M; Okamoto T; Suda K; Shimokawa M; Kitahara H; Shimamatsu S; Konishi H; Yoshida T; Takenoyama M; Yano T; Maehara Y
    Clin Cancer Res; 2014 Jul; 20(13):3613-22. PubMed ID: 24803578
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
    Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
    Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
    [TBL] [Abstract][Full Text] [Related]  

  • 105. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.
    de Miguel FJ; Pajares MJ; Martínez-Terroba E; Ajona D; Morales X; Sharma RD; Pardo FJ; Rouzaut A; Rubio A; Montuenga LM; Pio R
    Mol Oncol; 2016 Nov; 10(9):1437-1449. PubMed ID: 27555542
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Expression of RNA-binding motif 10 is associated with advanced tumor stage and malignant behaviors of lung adenocarcinoma cancer cells.
    Guan G; Li R; Tang W; Liu T; Su Z; Wang Y; Tan J; Jiang S; Wang K
    Tumour Biol; 2017 Mar; 39(3):1010428317691740. PubMed ID: 28347232
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
    Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
    Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
    [TBL] [Abstract][Full Text] [Related]  

  • 108. RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer.
    Reyes A; Afkhami M; Massarelli E; Fricke J; Mambetsariev I; Li X; Velasquez G; Salgia R
    Clin Lung Cancer; 2024 Jul; ():. PubMed ID: 39138107
    [TBL] [Abstract][Full Text] [Related]  

  • 109. A cell-based splicing reporter system to identify regulators of cis-splicing between adjacent genes.
    Chwalenia K; Qin F; Singh S; Li H
    Nucleic Acids Res; 2019 Feb; 47(4):e24. PubMed ID: 30590765
    [TBL] [Abstract][Full Text] [Related]  

  • 110. PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C.
    Xu N; Ren Y; Bao Y; Shen X; Kang J; Wang N; Wang Z; Han X; Li Z; Zuo J; Wei GH; Wang Z; Zong WX; Liu W; Xie G; Wang Y
    Cell Rep; 2023 Sep; 42(9):113041. PubMed ID: 37682709
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Deregulation of splicing factors and breast cancer development.
    Silipo M; Gautrey H; Tyson-Capper A
    J Mol Cell Biol; 2015 Oct; 7(5):388-401. PubMed ID: 25948865
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The global landscape of intron retentions in lung adenocarcinoma.
    Zhang Q; Li H; Jin H; Tan H; Zhang J; Sheng S
    BMC Med Genomics; 2014 Mar; 7():15. PubMed ID: 24646369
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
    Pavel AB; Vasile CI
    J Bioinform Comput Biol; 2016 Dec; 14(6):1650031. PubMed ID: 27712196
    [TBL] [Abstract][Full Text] [Related]  

  • 114. RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report.
    Majd NK; Metrus NR; Santos-Pinheiro F; Trevino CR; Fuller GN; Huse JT; Chung C; Ketonen L; Anderson MD; Penas-Prado M
    Cancer Genet; 2019 Feb; 231-232():41-45. PubMed ID: 30803556
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Targeting dysregulated splicing factors in cancer: lessons learned from RBM10 deficiency.
    Wang Y; Wang Z
    J Mol Cell Biol; 2024 Apr; 15(10):. PubMed ID: 37827547
    [No Abstract]   [Full Text] [Related]  

  • 116. Genome Sequencing and RNA-Motif Analysis Reveal Novel Damaging Noncoding Mutations in Human Tumors.
    Singh B; Trincado JL; Tatlow PJ; Piccolo SR; Eyras E
    Mol Cancer Res; 2018 Jul; 16(7):1112-1124. PubMed ID: 29592900
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.
    Bieging-Rolett KT; Kaiser AM; Morgens DW; Boutelle AM; Seoane JA; Van Nostrand EL; Zhu C; Houlihan SL; Mello SS; Yee BA; McClendon J; Pierce SE; Winters IP; Wang M; Connolly AJ; Lowe SW; Curtis C; Yeo GW; Winslow MM; Bassik MC; Attardi LD
    Mol Cell; 2020 Nov; 80(3):452-469.e9. PubMed ID: 33157015
    [TBL] [Abstract][Full Text] [Related]  

  • 118. RBM10 Regulates Tumor Apoptosis, Proliferation, and Metastasis.
    Cao Y; Di X; Zhang Q; Li R; Wang K
    Front Oncol; 2021; 11():603932. PubMed ID: 33718153
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Star-PAP RNA Binding Landscape Reveals Novel Role of Star-PAP in mRNA Metabolism That Requires RBM10-RNA Association.
    Koshre GR; Shaji F; Mohanan NK; Mohan N; Ali J; Laishram RS
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576144
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Identification of lung cancer drivers by comparison of the observed and the expected numbers of missense and nonsense mutations in individual human genes.
    Gorlova OY; Kimmel M; Tsavachidis S; Amos CI; Gorlov IP
    Oncotarget; 2022; 13():756-767. PubMed ID: 35634240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.